Engraftment in the fetal sheep model
Cell dose . | 1° Recipient . | 2° Recipient . | 3° Recipient . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group . | N . | % Engraftment . | CD45+× 1044-150 . | % CD34+ . | |||||||||
2 mo‡ . | 6 mo4-153 . | Group . | N . | % Engraftment‡ . | MNC × 1064-151 . | Group . | N . | % Engraftment‡ . | |||||
1 × 105 | I | 4 | 4.8 ± 0.7 | 4.1 ± 0.5 | 1.9 | 17.2 | IV | 3 | 5.2 | 5.1 | VII | 3 | 4.7 |
D7 cultured | II | 4 | 6.3 ± 1.4 | 4.3 ± 0.9 | 2.3 | 13.9 | V | 3 | 4.4 | 3.9 | VIII | 3 | 0.80 |
D14 cultured | III | 4 | 5.6 ± 0.5 | 0.2 ± 0.2 | 1.7 | 7.2 | VI | 3 | < 0.05 | 4.2 | IX | 3 | 0 |
5 × 104 | X | 4 | 3.7 | ND | 3.3 | 11.3 | |||||||
D7 cultured | XI | 4 | 5.4 | ND | 1.8 | 12.4 | |||||||
D14 cultured | XII | 4 | 1.7 | ND | 1.8 | 5.3 |
Cell dose . | 1° Recipient . | 2° Recipient . | 3° Recipient . | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Group . | N . | % Engraftment . | CD45+× 1044-150 . | % CD34+ . | |||||||||
2 mo‡ . | 6 mo4-153 . | Group . | N . | % Engraftment‡ . | MNC × 1064-151 . | Group . | N . | % Engraftment‡ . | |||||
1 × 105 | I | 4 | 4.8 ± 0.7 | 4.1 ± 0.5 | 1.9 | 17.2 | IV | 3 | 5.2 | 5.1 | VII | 3 | 4.7 |
D7 cultured | II | 4 | 6.3 ± 1.4 | 4.3 ± 0.9 | 2.3 | 13.9 | V | 3 | 4.4 | 3.9 | VIII | 3 | 0.80 |
D14 cultured | III | 4 | 5.6 ± 0.5 | 0.2 ± 0.2 | 1.7 | 7.2 | VI | 3 | < 0.05 | 4.2 | IX | 3 | 0 |
5 × 104 | X | 4 | 3.7 | ND | 3.3 | 11.3 | |||||||
D7 cultured | XI | 4 | 5.4 | ND | 1.8 | 12.4 | |||||||
D14 cultured | XII | 4 | 1.7 | ND | 1.8 | 5.3 |
Fetal sheep were transplanted with fresh or ex vivo–cultured UCB CD34+ cells from multiple donors (group I-III) or a single donor (group X-XII). After 2 or 6 months, marrow was obtained and the frequency of human CD45+ cells determined by flow cytometry. As described in “Materials and methods,” CD45+ cells or bone marrow mononuclear cells (BMMNC) were then transferred to secondary and tertiary recipients, respectively. These secondary and tertiary recipients were killed after 2 months and human cell engraftment determined. Results are derived from a single experiment.
Total number of CD45+ cells recovered from 2 fetal sheep. These cells were split and given to 3 secondary recipients.
Total number of BMMNC cells recovered from 3 secondary recipients. These cells were split and given to 3 tertiary recipients.
Engraftment (mean ± SEM) of 2 fetal sheep killed at 2 months after transplantation.
Engraftment (mean ± SEM) of 2 sheep at 6 months after transplantation.
ND indicates not determined.